Century Therapeutics, Inc. (IPSC)
NASDAQ: IPSC · IEX Real-Time Price · USD
2.210
-0.200 (-8.30%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Century Therapeutics Market Cap
Century Therapeutics has a market cap or net worth of $186.75 million as of July 2, 2024. Its market cap has decreased by -7.82% in one year.
Market Cap
186.75M
Enterprise Value
37.00M
1-Year Change
-7.82%
Ranking
Category
Stock Price
$2.21
Market Cap Chart
Since the IPO on June 18, 2021, Century Therapeutics's market cap has decreased from $1.05B to $186.75M, a decrease of -82.23%. That is a compound annual growth rate of -43.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 199.70M | 0.50% |
| Dec 29, 2023 | 198.70M | -34.31% |
| Dec 30, 2022 | 302.50M | -65.09% |
| Dec 31, 2021 | 866.60M | -17.54% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Senseonics Holdings | 210.12M |
| Eliem Therapeutics | 209.75M |
| Akebia Therapeutics | 208.42M |
| 2seventy bio | 208.19M |
| Prelude Therapeutics | 207.08M |
| Trevi Therapeutics | 203.56M |
| ChromaDex | 203.20M |
| MultiPlan | 203.13M |